IBRX vs VRTX: Which Stock is Better?
Side-by-side comparison of Immunitybio Inc and Vertex Pharmaceuticals Inc in 2026
IBRX
Immunitybio Inc
$8.20
VRTX
Vertex Pharmaceuticals Inc
$439.18
Key Metrics Comparison
| Metric | IBRX | VRTX | Winner |
|---|---|---|---|
| Market Cap | $7.95B | $112.22B | VRTX |
| P/E Ratio | N/A | 28.82 | VRTX |
| EPS (TTM) | $N/A | $15.31 | VRTX |
| Revenue Growth | 4.1% | 0.1% | IBRX |
| Gross Margin | 99.3% | 53.7% | IBRX |
Analyze IBRX
Full quant analysis
Analyze VRTX
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is IBRX or VRTX a better investment?
Comparing IBRX and VRTX: Immunitybio Inc has a market cap of $7.95B while Vertex Pharmaceuticals Inc has $112.22B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between IBRX and VRTX?
IBRX (Immunitybio Inc) and VRTX (Vertex Pharmaceuticals Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: IBRX or VRTX?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: IBRX or VRTX?
IBRX has higher revenue growth at 4.1% vs 0.1% for VRTX.
Which company is more profitable: IBRX or VRTX?
Immunitybio Inc (IBRX) has higher gross margins at 99.3% compared to 53.7% for VRTX.
Which is the larger company: IBRX or VRTX?
Vertex Pharmaceuticals Inc (VRTX) is larger with a market cap of $112.22B compared to $7.95B for IBRX.
Should I buy IBRX or VRTX in 2026?
Both IBRX and VRTX have investment merit. IBRX trades at $8.20 while VRTX trades at $439.18. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between IBRX and VRTX stock?
Key differences: Market Cap ($7.95B vs $112.22B), P/E Ratio (N/A vs 28.8x), Revenue Growth (4.1% vs 0.1%), Gross Margin (99.3% vs 53.7%).